1 Market Overview

• 1.1 Product Overview and Scope of Anti-Ageing Drugs
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Anti-Ageing Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
  • 1.3.2 Hormonal Therapy
  • 1.3.3 Antioxidants
  • 1.3.4 Enzymes
  • 1.3.5 Stem Cells
  • 1.3.6 Others
• 1.4 Market Analysis by Application
  • 1.4.1 Overview: Global Anti-Ageing Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
  • 1.4.2 Skin
  • 1.4.3 Hair
  • 1.4.4 Others
• 1.5 Global Anti-Ageing Drugs Market Size & Forecast
  • 1.5.1 Global Anti-Ageing Drugs Consumption Value (2019 & 2023 & 2030)
  • 1.5.2 Global Anti-Ageing Drugs Sales Quantity (2019-2030)
  • 1.5.3 Global Anti-Ageing Drugs Average Price (2019-2030)

2 Manufacturers Profiles

• 2.1 Nu Skin
  • 2.1.1 Nu Skin Details
  • 2.1.2 Nu Skin Major Business
  • 2.1.3 Nu Skin Anti-Ageing Drugs Product and Services
  • 2.1.4 Nu Skin Anti-Ageing Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.1.5 Nu Skin Recent Developments/Updates
• 2.2 BIOTIME
  • 2.2.1 BIOTIME Details
  • 2.2.2 BIOTIME Major Business
  • 2.2.3 BIOTIME Anti-Ageing Drugs Product and Services
  • 2.2.4 BIOTIME Anti-Ageing Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.2.5 BIOTIME Recent Developments/Updates
• 2.3 Elysium Health
  • 2.3.1 Elysium Health Details
  • 2.3.2 Elysium Health Major Business
  • 2.3.3 Elysium Health Anti-Ageing Drugs Product and Services
  • 2.3.4 Elysium Health Anti-Ageing Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.3.5 Elysium Health Recent Developments/Updates
• 2.4 La Roche-Posay
  • 2.4.1 La Roche-Posay Details
  • 2.4.2 La Roche-Posay Major Business
  • 2.4.3 La Roche-Posay Anti-Ageing Drugs Product and Services
  • 2.4.4 La Roche-Posay Anti-Ageing Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.4.5 La Roche-Posay Recent Developments/Updates
• 2.5 DermaFix
  • 2.5.1 DermaFix Details
  • 2.5.2 DermaFix Major Business
  • 2.5.3 DermaFix Anti-Ageing Drugs Product and Services
  • 2.5.4 DermaFix Anti-Ageing Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.5.5 DermaFix Recent Developments/Updates

3 Competitive Environment: Anti-Ageing Drugs by Manufacturer

• 3.1 Global Anti-Ageing Drugs Sales Quantity by Manufacturer (2019-2024)
• 3.2 Global Anti-Ageing Drugs Revenue by Manufacturer (2019-2024)
• 3.3 Global Anti-Ageing Drugs Average Price by Manufacturer (2019-2024)
• 3.4 Market Share Analysis (2023)
  • 3.4.1 Producer Shipments of Anti-Ageing Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
  • 3.4.2 Top 3 Anti-Ageing Drugs Manufacturer Market Share in 2023
  • 3.4.2 Top 6 Anti-Ageing Drugs Manufacturer Market Share in 2023
• 3.5 Anti-Ageing Drugs Market: Overall Company Footprint Analysis
  • 3.5.1 Anti-Ageing Drugs Market: Region Footprint
  • 3.5.2 Anti-Ageing Drugs Market: Company Product Type Footprint
  • 3.5.3 Anti-Ageing Drugs Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Anti-Ageing Drugs Market Size by Region
  • 4.1.1 Global Anti-Ageing Drugs Sales Quantity by Region (2019-2030)
  • 4.1.2 Global Anti-Ageing Drugs Consumption Value by Region (2019-2030)
  • 4.1.3 Global Anti-Ageing Drugs Average Price by Region (2019-2030)
• 4.2 North America Anti-Ageing Drugs Consumption Value (2019-2030)
• 4.3 Europe Anti-Ageing Drugs Consumption Value (2019-2030)
• 4.4 Asia-Pacific Anti-Ageing Drugs Consumption Value (2019-2030)
• 4.5 South America Anti-Ageing Drugs Consumption Value (2019-2030)
• 4.6 Middle East and Africa Anti-Ageing Drugs Consumption Value (2019-2030)

5 Market Segment by Type

• 5.1 Global Anti-Ageing Drugs Sales Quantity by Type (2019-2030)
• 5.2 Global Anti-Ageing Drugs Consumption Value by Type (2019-2030)
• 5.3 Global Anti-Ageing Drugs Average Price by Type (2019-2030)

6 Market Segment by Application

• 6.1 Global Anti-Ageing Drugs Sales Quantity by Application (2019-2030)
• 6.2 Global Anti-Ageing Drugs Consumption Value by Application (2019-2030)
• 6.3 Global Anti-Ageing Drugs Average Price by Application (2019-2030)

7 North America

• 7.1 North America Anti-Ageing Drugs Sales Quantity by Type (2019-2030)
• 7.2 North America Anti-Ageing Drugs Sales Quantity by Application (2019-2030)
• 7.3 North America Anti-Ageing Drugs Market Size by Country
  • 7.3.1 North America Anti-Ageing Drugs Sales Quantity by Country (2019-2030)
  • 7.3.2 North America Anti-Ageing Drugs Consumption Value by Country (2019-2030)
  • 7.3.3 United States Market Size and Forecast (2019-2030)
  • 7.3.4 Canada Market Size and Forecast (2019-2030)
  • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

• 8.1 Europe Anti-Ageing Drugs Sales Quantity by Type (2019-2030)
• 8.2 Europe Anti-Ageing Drugs Sales Quantity by Application (2019-2030)
• 8.3 Europe Anti-Ageing Drugs Market Size by Country
  • 8.3.1 Europe Anti-Ageing Drugs Sales Quantity by Country (2019-2030)
  • 8.3.2 Europe Anti-Ageing Drugs Consumption Value by Country (2019-2030)
  • 8.3.3 Germany Market Size and Forecast (2019-2030)
  • 8.3.4 France Market Size and Forecast (2019-2030)
  • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
  • 8.3.6 Russia Market Size and Forecast (2019-2030)
  • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

• 9.1 Asia-Pacific Anti-Ageing Drugs Sales Quantity by Type (2019-2030)
• 9.2 Asia-Pacific Anti-Ageing Drugs Sales Quantity by Application (2019-2030)
• 9.3 Asia-Pacific Anti-Ageing Drugs Market Size by Region
  • 9.3.1 Asia-Pacific Anti-Ageing Drugs Sales Quantity by Region (2019-2030)
  • 9.3.2 Asia-Pacific Anti-Ageing Drugs Consumption Value by Region (2019-2030)
  • 9.3.3 China Market Size and Forecast (2019-2030)
  • 9.3.4 Japan Market Size and Forecast (2019-2030)
  • 9.3.5 Korea Market Size and Forecast (2019-2030)
  • 9.3.6 India Market Size and Forecast (2019-2030)
  • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
  • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

• 10.1 South America Anti-Ageing Drugs Sales Quantity by Type (2019-2030)
• 10.2 South America Anti-Ageing Drugs Sales Quantity by Application (2019-2030)
• 10.3 South America Anti-Ageing Drugs Market Size by Country
  • 10.3.1 South America Anti-Ageing Drugs Sales Quantity by Country (2019-2030)
  • 10.3.2 South America Anti-Ageing Drugs Consumption Value by Country (2019-2030)
  • 10.3.3 Brazil Market Size and Forecast (2019-2030)
  • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

• 11.1 Middle East & Africa Anti-Ageing Drugs Sales Quantity by Type (2019-2030)
• 11.2 Middle East & Africa Anti-Ageing Drugs Sales Quantity by Application (2019-2030)
• 11.3 Middle East & Africa Anti-Ageing Drugs Market Size by Country
  • 11.3.1 Middle East & Africa Anti-Ageing Drugs Sales Quantity by Country (2019-2030)
  • 11.3.2 Middle East & Africa Anti-Ageing Drugs Consumption Value by Country (2019-2030)
  • 11.3.3 Turkey Market Size and Forecast (2019-2030)
  • 11.3.4 Egypt Market Size and Forecast (2019-2030)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
  • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

• 12.1 Anti-Ageing Drugs Market Drivers
• 12.2 Anti-Ageing Drugs Market Restraints
• 12.3 Anti-Ageing Drugs Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Anti-Ageing Drugs and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Anti-Ageing Drugs
• 13.3 Anti-Ageing Drugs Production Process
• 13.4 Anti-Ageing Drugs Industrial Chain

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Anti-Ageing Drugs Typical Distributors
• 14.3 Anti-Ageing Drugs Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Anti-Ageing Drugs market size was valued at USD 84440 million in 2023 and is forecast to a readjusted size of USD 137170 million by 2030 with a CAGR of 7.2% during review period.
Anti-aging drugs are used to slow down or reverse the processes of aging to extend the lifespan. Aging, is that damage to the body’s macromolecules, cells, tissues, which is facilitated by genomic instability, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, oxidation damage by free radicals etc
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Anti-Ageing Drugs industry chain, the market status of Skin (Hormonal Therapy, Antioxidants), Hair (Hormonal Therapy, Antioxidants), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Anti-Ageing Drugs.
Regionally, the report analyzes the Anti-Ageing Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Anti-Ageing Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Anti-Ageing Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Anti-Ageing Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Hormonal Therapy, Antioxidants).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Anti-Ageing Drugs market.
Regional Analysis: The report involves examining the Anti-Ageing Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Anti-Ageing Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Anti-Ageing Drugs:
Company Analysis: Report covers individual Anti-Ageing Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Anti-Ageing Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Skin, Hair).
Technology Analysis: Report covers specific technologies relevant to Anti-Ageing Drugs. It assesses the current state, advancements, and potential future developments in Anti-Ageing Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Anti-Ageing Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Anti-Ageing Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Hormonal Therapy
Antioxidants
Enzymes
Stem Cells
Others
Market segment by Application
Skin
Hair
Others
Major players covered
Nu Skin
BIOTIME
Elysium Health
La Roche-Posay
DermaFix
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-Ageing Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-Ageing Drugs, with price, sales, revenue and global market share of Anti-Ageing Drugs from 2019 to 2024.
Chapter 3, the Anti-Ageing Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-Ageing Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Anti-Ageing Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-Ageing Drugs.
Chapter 14 and 15, to describe Anti-Ageing Drugs sales channel, distributors, customers, research findings and conclusion.